These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7985587)

  • 1. Effect of angiographic and hemodynamic results of coronary balloon angioplasty on late angiographic outcome.
    Liu MW; Roubin GS; King SB
    Am Heart J; 1994 Dec; 128(6 Pt 1):1077-83. PubMed ID: 7985587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT).
    Baim DS; Cutlip DE; Sharma SK; Ho KK; Fortuna R; Schreiber TL; Feldman RL; Shani J; Senerchia C; Zhang Y; Lansky AJ; Popma JJ; Kuntz RE
    Circulation; 1998 Feb; 97(4):322-31. PubMed ID: 9468205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of residual stenosis in determining restenosis after cutting balloon angioplasty.
    Martí V; Salas E; Aymat RM; García J; Guiteras P; Romeo I; Kozak F; Augé JM
    Catheter Cardiovasc Interv; 2000 Apr; 49(4):410-4. PubMed ID: 10751767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome.
    Gershlick A; Brack MJ; More RS; Syndercombe-Court D; Balcon R
    Coron Artery Dis; 1993 Jan; 4(1):73-81. PubMed ID: 8269186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of late proven patency after successful coronary angioplasty.
    Weintraub WS; Ghazzal ZM; Cohen CL; Douglas JS; Liberman H; Morris DC; King SB
    Circulation; 1991 Aug; 84(2):572-82. PubMed ID: 1860202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.
    Lablanche JM; Grollier G; Lusson JR; Bassand JP; Drobinski G; Bertrand B; Battaglia S; Desveaux B; Juillière Y; Juliard JM; Metzger JP; Coste P; Quiret JC; Dubois-Randé JL; Crochet PD; Letac B; Boschat J; Virot P; Finet G; Le Breton H; Livarek B; Leclercq F; Béard T; Giraud T; Bertrand ME
    Circulation; 1997 Jan; 95(1):83-9. PubMed ID: 8994421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the residual translesional pressure gradient useful to predict regional myocardial perfusion after percutaneous transluminal coronary angioplasty?
    MacIsaac HC; Knudtson ML; Robinson VJ; Manyari DE
    Am Heart J; 1989 Apr; 117(4):783-90. PubMed ID: 2522717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
    Schmitz HJ; Erbel R; Meyer J; von Essen R
    Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary restenosis after optimal (stent-like) initial angiographic results obtained by traditional balloon angioplasty.
    Di Luzio V; De Remigis F; De Curtis G; Paparoni S; Pecce P; Di Emidio L; Prosperi F; D'Aroma A; Balducelli M; Maresta A
    G Ital Cardiol; 1997 Jul; 27(7):645-53. PubMed ID: 9282284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.